INTRODUCTION
The initiation of the disseminated inflammatory response to uncontrolled microbial infection involves the activation of soluble (complement and coagulation) and cellular (blood monocytes and neutrophils) components of innate immunity. Of the cellular processes, the stimulation of Toll-like receptors (TLR) expressed on mammalian cells by some well-characterized molecules (LPS via TLR4, 1 CpG DNA via TLR9, 2 MalP via TLR2 3 ) are sufficient to initiate a spectrum of disastrous pathologies, which we herein refer to as septicemia. Septicemia is the major cause of death in intensive care units. 4 There are common elements in the pathophysiology of septicemia: (i) all mammals thus far studied react similarly; (ii) prototypical sets of genes are expressed by leukocytes (probably those circulating in blood and fixed in tissues); (iii) among the essential genes required for inducing septicemia are those encoding TNF-a and IL-1b; (iv) TLR receptors and their downstream signaling pathways play critical roles inducing and adapting to the products of infecting micro-organisms; (v) septicemia is autodestructive and carries high morbidity and mortality; and (vi) septicemia is extremely difficult to treat, once initiated.
Gene-and signal-specific adaptation/tolerance of blood leukocytes to lipopolysaccharide endotoxin (LPS) occurs during human and animal septicemia. These phenotypes can be modeled in vitro. LPS-TLR4-adapted human THP-1 promonocytic cells cross-adapt to lipoteichoic acid (LTA)-TLR2induced IL-1b/TNF-a production, suggesting disruption of a common intracellular signaling event(s). A plausible explanation for homologous adaptation of TLR4 with heterologous adaptation of TLR2 is a persistent inactivation and degradation of IRAK1 following TLR4 activation. LTA stimulation of TLR2 also produces homologous adaptation of TLR2 with inactivation of IRAK1, but there is no detectable degradation of IRAK1. Strikingly, such LTA-adapted cells still respond to LPS stimulation of TLR4 with rapid activation and degradation of IRAK1, and robust IL-1b/TNFa production. Moreover, cells adapted to either LTA-or LPS-production of IL-1b/TNF-a normally produce soluble interleukin 1 receptor antagonist (sIL-1Ra) anti-inflammatory protein when stimulated by either agonist. We conclude that: (i) disruption of a unique TLR2 signaling component upstream of IRAK1, but downstream of TLR2 sensing, induces homologous adaptation to LTA; (ii) disruption of IRAK1 may induce homologous adaptation of TLR4 to LPS and crossadaptation of TLR2 to LTA; and (iii) TLR2/TLR4 signaling events that control sIL-1Ra translation do not adapt to LPS or LTA, indicating that TLR4 and TLR2 can still function. We present a hypothetical model of adaptation based on a signalsome, with IRAK1 evolving after IRAK4 to regulate TLR4 adaptation tightly.
We espouse other common features of septicemia in Figure 1 . This model applies to human and animal septicemia induced by a variety of microbes, but it is best characterized in cell models such as TLR4 responses to LPS. The lines represent different patterns of gene expression by blood leukocytes. First, there is rapid expression of pro-inflammatory genes (e.g. genes encoding TNF-a and IL-1b) that trigger septicemia. Following this, there is repressed transcription of these acute pro-inflammatory genes that initiate septicemia, 5 a phenotype that persists during clinical septicemia. Other genes that are expressed during early septicemia are not suppressed, a phenotype that also persists during the clinical illness. These chronically expressed genes include those encoding both antiinflammatory and chronic inflammatory mediators.
There are common features that regulate expression of the genes that are rapidly repressed after initial expression. These genes are tightly regulated by overlapping transcription factors (e.g. NF-kB, AP1), 6, 7 and by post-transcriptional events that control rapid degradation of AU-rich mRNAs (as discussed by Learn et al. 8 ).
Less is known about the regulation of expression of antiinflammatory mediators. In the case of sIL-1Ra, it involves a PI-3 kinase/Akt pathway that controls a selective and highly efficient translational process. 9 It is not known whether this applies to other anti-inflammatory genes such as those encoding IL-6 and IL-10. Less yet is know about the molecular controls of the gene products that might be classified as chronic inflammatory mediators. This group, which includes high mobility group-1 (HMG-1), 10 macrophage inhibitory factor (MIF), 11, 12 and calgranulins A and B/S100s/macrophage-related proteins 8 and 14 (MRP8/MRP14; unpublished observations), may be particularly important in sustaining tissue injury during septicemia. Collectively, we refer to the overall pattern shown in Figure 1 as the sepsis leukocyte phenotype, since the identification of these phenotypes is now limited to studies of phagocytic leukocytes (monocytes and neutrophils).
We advocate that there are stable features of the human sepsis leukocyte phenotype depicted in Figure 1 ; that is, they persist during clinical septicemia. An example of this is the pattern of expression of IL-1b and sIL-1Ra in the basal and LPS-stimulated state of blood leukocytes obtained from normal and septic humans ( Fig. 2 ). 13 This pattern is remarkably consistent during the course of human septicemia. 13, 14 We have also observed (unpublished data) the stability of this phenotype in baboons with Escherichia coli septicemia, where it exists for 7-9 days and subsides in baboons recovering from the disease. At this time, the IL-1b gene is no longer repressed and sIL-1Ra is not constitutively expressed.
This manuscript summarizes our data, interpretations and concepts on the role of the interleukin receptor associated kinase family (IRAK1, IRAK2, IRAKM, and IRAK4) in influencing the human sepsis leukocyte phenotype. We emphasize the IRAK1 member of the IRAK family as it participates in the signaling events linked to the stimulation/adaptation of TLR4 to LPS, compared with the stimulation/adaptation of TLR2 to lipoteichoic acid (LTA). We also discuss the signal-and gene-specific nature of the TLR4-and TLR2-adaptive phenotypes, and generate a hypothetical model for the role of the IRAK family in TLR signaling and TLR adaptation. 
MATERIALS AND METHODS

Models of the sepsis leukocyte phenotype
These include: (i) ex vivo study of whole blood leukocytes obtained from patients with septicemia as defined by Mueller et al. 13 -over 50% of these patients were in refractory cardiovascular 'shock'; and (ii) in vitro studies of undifferentiated THP-1 human promonocytes, 15 which in our hands is a faithful model to investigate the phenotype depicted in Figure 1 . Giving primary and secondary stimulation with produced phenotypic changes typical of whole blood leukocytes: LPS and LPS, LTA and LTA, LPS and LTA, and LTA and LPS. 16 Sequential stimuli were given 13-16 h apart, or in a defined timed analysis.
Phenotype analysis
Phenotype analysis was assessed as described previously, 16 and included mRNA analysis of TNF-a and/or IL-1b by Northern blots and semiquantitative PCR, and production of IL-1b and TNF-a protein by commercially available ELISA. Studies of IRAK included Western blot and in vitro kinase assays as described, as do those of Akt. 9 Wortmannin and LY294002 are used as relatively specific inhibitors of PI-3 kinase. 9
Microbial products used to stimulate TLR2 and TLR4
We used highly purified lipoteichoic acid (LTA), kindly provided by Tom Hartung as a TLR2-specific agonist. 17 Similar results of TLR2 stimulation occurred with synthetic lipopeptide (not shown). For TLR4-specific stimulation, we used commercial Sigma E. coli O111:B4 (LPS), which in our hands stimulates only via TLR4.
However, results were confirmed with highly purified LPS, kindly supplied by Stephanie Vogel.
RESULTS AND DISCUSSION
We first showed LPS-TLR4 dependent activation and subsequent inactivation and degradation of IRAK1 in human THP-1 monocytic cells. 18 The degradation of IRAK1 extends for up to 36 h and correlates with adaptation of TLR4 to further induction of IL-1b and TNF-a. Unresponsiveness of IRAK1 is also seen in LPS-adapted whole blood leukocytes obtained from humans with septicemia (referred to by Mueller et al. 13 and unpublished observations). In contrast to IRAK1, no degradation of IRAK2, 19 IRAK4, 20 or IRAK M (personal communication) occurs following stimulation of TLR4 with LPS. The observations of IRAK1 unresponsiveness in human monocytes and its correlation with adaptation of cells to LPS in human monocytes have been confirmed and extended. [21] [22] [23] Recently, we reported that, in striking contrast to LPS-induced inactivation and degradation of IRAK1 by LPS, stimulation of TLR2 by LTA activates but does not degrade IRAK1. 16 LPS induces homologous tolerance and cross-tolerance to LTA, while LTA only induces homologous tolerance to itself. A similar observation occurs with flagellin stimulation of TLR5. 24 The cross-adaptation of TLR2 and TLR5 following LPSinduced adaptation of TLR4 correlates with inactivation and degradation of IRAK1. The lack of cross-adaptation of TLR4 to LPS stimulation of IL-1b and TNF-a following homologous adaptation of TLR2 and TLR5 predicted that IRAK1 would be degraded following stimulation of TLR4 with LPS. Such was the case. 16 Innate immunity regulation is complex and highly tissue/cell as well as species specific. This complex nature may help different cells/tissues/organisms to combat and adapt to microbial infections. Correspondingly, there are apparent differences in the responses between human and murine cells. Distinct from the human cells, murine cells develop full cross-adaptation between LTA TLR2 responses, and LPS TLR4 responses. 17 Such difference may be caused by distinct underlying molecular regulation between species. For example, there are differences in both TLR4 and TLR9 responses to microbial stimulants between human and mouse. 25, 26 In addition, the fate of TLR receptors upon prolonged microbial stimulation is also distinct between human and murine cells. Prolonged LPS stimulation causes dramatic decreases in the murine macrophage TLR4 receptor level. 27 In contrast, human monocyte TRL4 receptor level remains constant and not altered upon prolonged LPS stimulation. 23, 28 GM-CSF prevents endotoxin tolerance in human monocytes by promoting IRAK expression and its association to MyD88, and not by modulating TLR4 expression. In agreement with these human studies, we reported that LPS stimulation of TLR4 of LPS-adapted human sepsis whole blood and LPSadapted THP-1 cells normally produce sIL-1Ra with the second stimulus. 9, 13 The normal production of sIL-1Ra occurs despite a repression in transcription of the gene and is the result of highly efficient translational process dependent on a TLR4-PI-3 kinase-Akt signaling pathway. We also find that THP-1 cells adapted to TLR2 stimulation by LTA can normally produce sIL-1Ra in response to either LTA or LPS. 16 Collectively, these observations support the concept that adaptive processes in human septicemia and in our THP-1 cell model (which closely mimics human sepsis blood leukocyte phenotype) lie distal to TLR2 and TLR4.
The complexities and variations of tolerance/cross-tolerance acquisition not only manifest among different species, but also among distinct microbial pathogen patterns and TLR receptors. As noted by us and others, LTA via TLR2 and FliC via TLR5 clearly induce distinct molecular alterations of IRAK1 and distinct adaptive phenotypes compared with LPS via TLR4. 16, 24 In Figure  3 , we depict our findings and concepts in human monocytes of homologous adaptation of TLR4 to LPS and homologous adaptation of TLR2 to LTA, as well as the one-way cross-tolerance observed between TLR4 and TLR2. It is even more intriguing to point out that there are four IRAK homologues in the human genome, namely IRAK1, IRAK2, IRAKM, and IRAK4. IRAK4 was recently discovered and represents the orthologue of the Pelle protein of the innate immune response in Drosophila. 20 Mice with deletions of IRAK4 are phenotypically similar to mice lacking the proximal adapter MyD88, and thereby are extremely susceptible to bacterial infection. 29 Animals with a deletion of IRAK1 are moderately susceptible to infection with Gram-negative bacteria, and partially resistant to LPS. 30 IRAK1, IRAK2, and IRAKM likely evolved later than IRAK4. IRAK4 physically interacts with the other IRAKs and presumably signals upstream of other IRAKs. 20 Interestingly, among all IRAKs, only IRAK1 can undergo IL-1b or microbial product-induced degradation. IRAK2, which is not degraded after TLR4 stimulation, is linked to a MyD88-independent pathway that involves TIRAP/MAL. 31, 32 It is tempting to hypothesize that the emergence of IRAK1 in evolution may correlate with acquisition of the ability to develop LPS adaptation/tolerance. Figure 4 depicts a hypothetical model based on an IRAK signalsome (containing IRAK4, IRAK1, IRAK2, and IRAKM) in mammalian cells, which might provide tight control over gene expression following TLR activation in septicemia. Note that Drosophila does not contain the IRAK signalsome, a TOLLIP or TIRAP orthologue. Thus, LPS adaptation may be unique to mammals. The overall functional implications of the sepsis leukocyte phenotype as depicted in Figures 1-4 are unclear, but the phenotype may contribute to a physiological compromise in the defensive properties of innate immunity, while promoting chronic inflammation by genes such as those encoding MIF, 33 HMG-1, 34 and the calgranulin/S100/MRP family (unpublished observations). Fig. 4 . A putative signalsome in mammals that adapt to LPS stimulation of TLR4 during septicemia. IRAK1, IRAK2, and IRAKM evolved after IRAK4 (whose orthologue is Pelle in Drosophila). IRAK1 plays a major role in repressing transcription of acute pro-inflammatory genes (e.g. IL-1b) and TNF-a. Drosophila signaling is depicted as less complex, and lacking the orthologues of adapters TOLLIP and possibly TIRAP/MAL.
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